In Vitro Bactericidal Activities of ABT-773 against ermB Strains of Streptococcus pneumoniae
AUTOR(ES)
Neuhauser, Melinda M.
FONTE
American Society for Microbiology
RESUMO
The bactericidal activities of ABT-773, a new ketolide, were compared to those of cefuroxime and amoxicillin-clavulanate against 10 strains of Streptococcus pneumoniae containing the ermB gene. MICs and time-kill curves were determined in duplicate per NCCLS guidelines with cation-adjusted Mueller-Hinton broth with 3% lysed horse blood. Viable counts were done at 0, 2, 6, and 24 h. Antibiotic concentrations tested were two and eight times the MIC. ABT-773 MICs ranged from 0.008 to 1.0 μg/ml. Bactericidal activity was observed with ABT-773 at eight times the MIC against 4 of 10 strains at 24 h compared to 10 of 10 strains with the beta-lactam antibiotics.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=149343Documentos Relacionados
- In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas
- Activities of ABT-773 against Microaerophilic and Fastidious Organisms
- Postantibiotic Effects of ABT-773 and Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae
- Comparative In Vitro Activities of ABT-773 against 362 Clinical Isolates of Anaerobic Bacteria
- In Vitro Activity of the Ketolide ABT-773